Immunology of diseases of the oral cavity

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 1517-1546

  Challacombe, Steven J ^a   Shirlaw, Penelope J ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72249122635     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50093-0     Document Type: Chapter

References (193)

1. Abiko Y. Passive immunisation against dental caries and periodontal disease: development of recombinant and human monoclonal antibodies. Crit. Revs. Oral. Biol. Med. 2000, 11:140-158.
2. Ahlfors E., Jonsson R., Czerkinsky C. Experimental T cell-mediated inflammatory reactions in the murine oral mucosa. II. Immunohistochemical characterization of resident and infiltrating cells. Clin. Exp. Immunol. 1996, 104:297-305.
3. Allen C.M., Camisa C. Paraneoplastic pemphigus: A review of the literature. Oral Dis. 2000, 6:208-214.
4. Amagai M. Towards a better understanding of pemphigus autoimmunity. Br. J. Dermatol. 2000, 143:237-238.
5. Amer A., Singh G., Darke C., Dolby A.E. Association between HLA antigens and periodontal disease. Tissue Antigens 1988, 31:53-58.
6. American Academy of Periodontology Proceedings of the World Workshop in Clinical Periodontics. Consensus Report 1989, 123-124. American Academy of Periodontology.
7. Bainbridge B.W., Darveau R.P. Porphyromonas gingivalis lipopolysaccharide: An unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol. Scand. 2001, 59:131-138.
8. Balding S., Prost C., Diaz L.A., Bernard P., Bedane C., Aberdam D., Giudice G.J. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J. Invest. Dermatol. 1996, 106:141-146.
9. Barnes R.M.R., Allen S., Taylor-Robinson C.H., Finn R., Johnson P.M. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: Is IgA antibody a marker for Crohn's disease?. Arch. Allergy Appl. Immunol. 1990, 92:9-15.
10. Bedane C., McMillan J.R., Balding S.D., Bernard P., Prost C., Bonnetblanc J.M., et al. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: Evidence that BP180 spans the lamina lucida. J. Invest. Dermatol. 1997, 108:901-907.
11. Behçet M. Uber rezidivierende Apthose durch ein virus verusachte gerchwere ammund, am Auge und an den Genitalien. Dermatol. Wochenschr. 1937, 105:1152-1157.
12. Berry H., Bacon P.A., Davis J.D. Cell mediated immunity in Sjögren's syndrome. Ann. Rheum. Dis. 1972, 31:298-302.
13. Bhan A.K., Harrist T.J., Murphy G.F., et al. T cell subsets and Langerhans cells in lichen planus in situ. Characterization using monoclonal antibodies. Br. J. Dermatol. 1981, 105:617-622.
14. Biesbrock A.R., Reddy M.S., Levine M.J. Interaction of salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect. Immun. 1991, 59:3492-3497.
15. Bistoni F., Cenci E., Mencacci A., Schiaffella E., Mosci P., Puccetti P., Romani L. Mucosal and systemic T helper cell function after intragastric colonisation of adult mice with Candida albicans. J. Infect. Dis. 1993, 168:1449-1457.
16. Booth V., Ashley F.P., Lehner T. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect. Immun. 1996, 64:422-427.
17. Borradori L., Sonnenberg A. Structure and function of hemidesmosomes: More than simple adhesion complexes. J. Invest. Dermatol. 1999, 112:411-418.
18. Brandtzaeg P. Inflammatory bowel disease: Clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogenesis?. Acta Odontol. Scand. 2001, 59:235-243.
19. Brown D.W., Furness J., Speight, et al. Mechanisms of binding of cutaneous lymphocyte associated antigen positive and alpha E beta 7 positive lymphocytes through oral and skin keratinocytes. Immunology 1999, 98:9-17.
20. Budtz-Jorgensen E. Immune response to Candida albicans in monkeys with experimental candidiasis in the palate. Scand. J. Dental Res. 1973, 81:360-371.
21. Bukawa H., Sekigawa K., Hamajima K., et al. Neutralization of HIV-1 by secretory IgG induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nature Med. 1995, 1:681-685.
22. Burgeson R.E. New collagens, new concepts. Annu. Rev. Cell Biol. 1988, 4:551-577.
23. Burgeson R.E., Chiquet N., Deutzmann R., Ekblom P., Engel J., Kleinman H., Martin G.R., Meneguzzi G., Paulsson M., Sanes J., Timpl R., Tryggvason K., Yamada Y., Yurchenko P.D. A new nomenclature for laminins. Matrix Biol. 1994, 14:209-211.
24. Buxton R.S., Magee A.I. Structure and interactions of desmosomal and other cadherins. Semin. Cell Biol. 1992, 3:157-167.
25. Challacombe S.J. Passage of immunoglobulins from serum to the oral cavity. The Borderland between Caries and Periodontal Disease II 1980, Vol. 2:51-67. Academic Press, San Diego, CA. T. Lehner, G. Cimasoni (Eds.).
26. Challacombe S.J. Serum and salivary antibodies to Streptococcus mutans in relation to the development and treatment of human dental caries. Arch. Oral Biol. 1980, 25:495-502.
27. Challacombe S.J. The induction of secretory IgA responses. Food Allergy and Intolerance 1987, Baillière Tindall, London. J. Brostoff, S.J. Challacombe (Eds.).
28. Challacombe S.J. Revised classification of HIV-associated oral lesions. Br. Dent. J. 1991, 170:305-306.
29. Challacombe S.J. Genetic and immune aspects of chronic inflammatory periodontal disease. Diseases of the Periodontium 1993, 27-53. Science Reviews, Wilmington, DE. H.N. Newman, T.D. Rees, D.F. Kinane (Eds.).
30. Challacombe S.J. Oro-facial granulomatosis and oral Crohn's disease: Are they specific diseases and do they predict systemic Crohn's disease?. Oral Dis. 1997, 3:127-129.
31. Challacombe S.J., Batchelor J.R., Kennedy L.A., Lehner T. HLA antigens in recurrent oral ulceration. Arch. Dermatol. 1977, 113:1717-1719.
32. Challacombe S.J., Bergmeier L.A., Rees A.S. Natural antibodies in man to a protein antigen from the bacterium Streptococcus mutans related to dental caries experience. Arch. Oral Biol. 1984, 29:179-184.
33. Challacombe S.J., Greenhall C., Biggerstaff M., Kemeny D.M. ELISA detection of human IgG sub-class antibodies to Streptococcus mutans. J. Immunol. Methods. 1986, 87:95-102.
34. Challacombe S.J., Giel N.M., Stephenson P.A., Wilton J.M.A. Antibodies and opsonic activity to plaque bacteria in human gingival crevicular fluid in relation to dental caries. Microbiol. Ecol. Dis. 1992, 5:21-30.
35. Challacombe S.J., Panayi G., Shirlaw P.J., Hockey K., Morgan P.R. SOX syndrome-sialadenitis, osteoarthritis and xerostomia presenting as Sjögren's syndrome. Clin. Exp. Rheumatol. 1991, 9:75.
36. Challacombe S.J., Rahman D., O'Hagan D. Oral, vaginal and nasal responses after intragastric immunisation with biodegradable microparticles. Vaccine 1997, 15:169-175.
37. Challacombe S.J., Russell M.W., Hawkes J.E., Bergmeier L.A., Lehner T. Passage of immunoglobulins from plasma to the oral cavity in rhesus monkeys. Immunology 1978, 35:923-931.
38. Challacombe S.J., Shirlaw P.J. Oral ulceration: When to treat, refer or ignore. Dental Update 1991, 52:368-373.
39. Challacombe S.J., Sweet S.P. Salivary and mucosal immune responses to HIV and its co-pathogens. Oral Dis. 1997, 3:79-84.
40. Champliaud M.-F., Lunstrum G.P., Rousselle P., Nishiyama T., Keene D.R., Burgeson R.E. Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelialstromal attachment. J. Cell. Biol. 1996, 132:1189-1198.
41. Chan L.S., Fine J.-D., Briggaman R.A., Woodley D.T., Hammerberg C., Drugge R.J., Cooper K.D. Identification and partial characterization of a novel immune-mediated subepidermal blistering disease. J. Invest. Dermatol. 1993, 101:262-267.
42. Chan L.S., Majmudar A.A., Tran H.H., Meier F., Schaumburg-Lever G., Chen M., Anhalt G., Woodley D.T., Marinkovich M.P. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J. Invest. Dermatol. 1997, 108:848-853.
43. Chen M., Chan L.S., Cai X., O'Toole E.A., Sample C., Woodley D.T. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J. Invest. Dermatol. 1997, 108:68-72.
44. Chia J.S., Lin S.W., Yang C.S., Chen J.Y. Antigenicity of a synthetic peptide from glucosyltransferases of Streptococcus mutans in humans. Infect. Immun. 1997, 65:126-130.
45. Childers N.K., Tong G., Li F., Dasanayake A.P., Michalek S.M. Jhuamns immunised with Streptococcus mutans antigens by mucosal routes. J. Dent. Res. 2002, 8:48-52.
46. Childerstone A., Altmann D., Haron J.A., Wilkinson D., Trowsdale J., Lehner T. An analysis of synthetic peptide restriction by HLA-DR alleles in T cells from human subjects, naturally sensitised by Streptococcus mutans. J. Immunol. 1991, 146:1439-1463.
47. Chused T.M., Kassan S.S., Opelz G., Moutsopolous H.M., Terasaki P.I. Sjögren's syndrome associated with HLA-DW3. N. Engl. J. Med. 1977, 296:896-897.
48. Cianciola L.J., Genco R.J., Patters M.R., McKenna J., Van Oss C.J. Defective polymorphonuclear leukocyte function in human periodontal disease. Nature (Lond.) 1977, 265:445-447.
49. Cooper B.T., Holmes G.K.T., Ferguson R. Glutensensitive diarrhoea without evidence of coeliac disease. Gastroenterology 1991, 79:801-806.
50. Crawford J.M., Watanabe K. Cell adhesion molecules in inflammation and immunity: Relevance to periodontal diseases. Crit. Rev. Oral Biol. Med. 1994, 5:91-123.
51. Cumberbatch M., Griffiths C.E., Tucker S.C., Dearman R.J., Kimber I. Tumour necrosis factor alpha induces Langerhan's cell migration in humans. Br. J. Dermatol. 1999, 141:192-200.
52. Czerkinsky C., Rees A.S., Bergmeier L.A., Challacombe S.J. The detection and specificity of class specific antibodies to whole bacterial cells using a solid phase radioimmunoassay. Clin. Exp. Immunol. 1983, 53:192-200.
53. Czerkinsky C., Quiding M., Eriksson K., Nordstrom I, Lakew M., Weneras C., Kilander A., Bjorck S., Svennerholm A.M., Butcher E., et al. Induction of specific immunity at mucosal surfaces: Prospects for vaccine development. Adv. Exp. Med. Biol. 1995, 371B:1409-1416.
54. Czerkinsky C., Sun J.B., Lebens M., Li B.L., Rask C., Lindblad M., Holmgren J. Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity. Ann. N.Y. Acad. Sci. 1996, 778:185-193.
55. De Panfilis G., Manara G., Sansoni P., Allegra F. T-cell infiltrate in lichen planus. Demonstration of activated lymphocytes using monoclonal antibodies. J. Cutan. Pathol. 1983, 10:52-58.
56. Diaz L.A., Calvanico N.J., Tomasi T.B.J., Jordon R.E. Bullous pemphigoid antigen: Isolation from normal human skin. J. Immunol. 1977, 118:455-460.
57. Dunsche A., Acil Y., Dommunisch H., Siebert R., Schroder J.M., Jepsen S. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur. J. Oral Sci. 2002, 110:121-124.
58. Dzink J.L., Tanner A.C.R., Haffajee A.D., Socransky S.S. Gram-negative species associated with active destructive periodontal lesions. J. Clin. Peridontal. 1985, 12:648-659.
59. Ebersole J.L. Systemic humoral immune responses in periodontal disease. Crit. Rev. Oral Biol. Med. 1990, 1:283-331.
60. Ebersole J.L., Cappelli D., Holt S.C. Periodontal diseases: To protect or not to protect is the question. Acta Odontol. Scand. 2001, 59:161-166.
61. Ebersole J.L., Cappelli D., Steffen M.J., Willmann D.E., O'Dell D.S. Host response assessment in recurring periodontitis. J. Clin. Periodontol. 1996, 23:258-262.
62. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus Classification and diagnostic criteria for oral lesions in HIV infection. J. Oral Pathol. Med. 1993, 22:289-291.
63. Eglin R.P., Lehner T., Subak-Sharpe J.H. Detection of RNA complementary to herpes simplex virus in mononuclear cells from patients with Behçet's syndrome and ROU. Lancet 1982, 2:1356-1361.
64. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as a vacine delivery system. Mol. Immunol. 1991, 28:287-294.
65. Eversole L.R., Dam J., Ficarra G., Hwang C.Y. Leukocyte adhesion molecules in oral lichen planus: A T cell-mediated immunopathologic process. Oral Microbiol. Immunol. 1994, 9:376-383.
66. Farah C.S., Ashman R.B., Challacombe S.J. Oral candidosis. Clinics in dermatology 2002, 18:553-562.
67. Ferguson M.M., Wray D., Carmichael H.A., Russel R.I., Lee F.D. Coeliac disease associated with recurrent aphthae. Gut 1980, 21:223-226.
68. Field E.A., Tyldesley W.R. Oral Crohn's disease revisited-a ten year review. Br. J. Oral Surg. 1989, 27:1114-1123.
69. Fontana M., Gfell L.E., Gregory R.L. Characterisation of preparations enriched for Streptococcus mutans fimbriae: Salivary immunoglobulin A antibodies in caries-free and caries-active subjects. Clin. Diag. Lab. Immunol. 1995, 2:719-725.
70. Freemont A.J., Hoyland J.A. Cell adhesion molecules. JCP Clin. Mol. Pathol. 1996, 49:321-330.
71. Frenette P.S., Wagner D.A. Molecular medicine. Adhesion molecules-Part I. N. Engl. J. Med. 1996, 334:1526-1529.
72. Friedman A., Weiner H.L. Induction of energy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 1994, 91:6688-6692.
73. Garside P., Mowat A.M. Mechanisms of oral tolerance. Crit. Rev. Immunol. 1997, 17:119-137.
74. Gaston J.S., Rowe M., Bacon P. Sjögren's syndrome after infection by Epstein-Barr virus. J. Rheumatol. 1990, 17:558-561.
75. Genco R.J., Slots J. Host responses in periodontal diseases. J. Dent. Res. 1984, 63:441-451.
76. Giudice G.J., Emery D.J., Diaz L.A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen, BP180. J. Invest. Dermatol. 1992, 99:243-250.
77. Giudice G.J., Squiquera H.L., Elias P.M., Diaz L.A. Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J. Clin. Invest. 1991, 87:734-738.
78. Greenspan D., Greenspan J.S. Management of the oral lesions of HIV infection. J. Amer. Dental Association 1991, 122:26-32.
79. Greenspan J.S. Sentinels and signposts: The epidemiology and significance of the oral manifestations of HIV disease. Oral Dis. 1997, 3:S13-S17. (Suppl).
80. Gumbiner B.M. Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 1996, 84:345-357.
81. Guo L., Degenstein L., Dowling J., Yu Q-C., Wollmann R., Perman B., Fuchs E. Gene targeting of BPAG1: Abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 1995, 81:233-443.
82. Hajishengallis G., Michalek S.M. Current status of a mucosal vaccine against Dental Caries. Oral Microbiol. Immunol. 1999, 14:1-20.
83. Han Y., Cutler J.E. Antibody response that protects against disseminated candidiasis. Infect. Immun. 1995, 63:2714-2719.
84. Han Y., Riesselman M.H., Cutler J.E. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. 2000, 68:1649-1654.
85. Harman K.E., Seed P.T., Gratian M.J., Bhogal B.S., Challacombe S.J., Black M.M. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br. J. Derm. 2001, 144:775-780.
86. Hasan A., Childerstone A., Pervin K., Shinnick T., Mizushima Y., Van der Zee R., Vaughan R., Lehner T. Recognition of a unique peptide epitope of the mycobacterial and human heat shock protein 65-60 antigen by T cells of patients with recurrent oral ulcers. Clin. Exper. Immunol. 1995, 99:392-397.
87. Hasan A., Shinnick T., Mizushima Y., van der Zee R., Lehner T. Defining a T-cell epitope within HSP 65 in recurrent aphthous stomatitis. Clin. Exp. Immunol. 2002, 128:318-325.
88. Hill I.R., Porter P. Studies of bactericidal activity to Escherichia coli of porcine serum and colostral immunoglobulins and the role of lysozyme with secretory IgA. Immunology 1974, 26:1239-1250.
89. Hirako Y., Usukura J., Nishizawa Y., Owaribe K. Demonstration of the molecular shape of BP180, a 180kDa bullous pemphigoid antigen and its potential for trimer formation. J. Biol. Chem. 1996, 27:13739-13745.
90. Hopkinson S.B., Baker S.E., Jones J.C.R. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180) identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and α6 integrin. J. Cell Biol. 1995, 99:264-270.
91. Ishiko A., Shimizu H., Kikuchi A., Ebihara T., Hashimoto T., Nishikawa T. Human autoantibodies against 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J. Clin. Invest. 1993, 91:1608-1615.
92. Jenkinson H.F., Demuth R. Structure, function and immunogenicity of streptococcal antigen I/II polypeptides. Mol. Microbiol. 1997, 23:183-190.
93. Jordan R.C., Odell E.W., Speight P.M. B-cell monoclonality in salivary lymphoepithelial lesions. Eur. J. Cancer B. Oral Oncol. 1996, 32B:38-44.
94. Kaslick R.S., West T.L., Chasens A.I. Association between ABO blood groups, HLA antigens and periodontal disease in young adults: A follow-up study. J. Periodont. Res. 1980, 51:339-342.
95. Kazmi S.H., Sweet S.P., Evans R.W., O'Shea S., Banatvala J.E., Challacombe S.J. Comparison of HIV-1 specific inhibitory activity in saliva and other mucosal fluids. J. Inf. Dis. 2003, in press.
96. Kassimos D.G., Shirlaw P.J., Choy E.H.S., Hockey K., Morgan P.R., Challacombe S.J., Panayi G.S. Chronic sialadenitis patients with nodal osteoarthritis. Br. J. Rheumatol. 1997, 36:1312-1317.
97. Katz J., Goultschin J., Benoliel R., Braubar C. Human leukocyte antigen (HLA) DR. Positive association with rapidly progressing periodontitis. J. Periodontol. 1987, 58:606-610.
98. Kelly C.G., Todryk S., Kendal H.L., Munro G.H., Lehner T. T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans antigen 1/11. Infect. Immun. 1995, 63:3649-3658.
99. Kelly C.G., Younson J.S., Hikmat B.Y., Todryk S.M., Czisch M., Haris P.I., Flindall I.R., Newby C., Mallet A.I., Ma J.K., Lehner T. A synthetic peptide adhesion epitope as a novel antimicrobial agent. Nat. Biotech. 1999, 17:42-47.
100. Klouda P.T., Porter S.R., Scully C., Corbin S.A., Bradley B.A., Smith A., Davies R.M. Association between HLA-A9 and rapidly progressive periodontitis. Tissue Antigens 1986, 28:146-149.
101. Kolopp-Sarda M.N., Béné M.E., Allaire J.M., Perruchet A.M., Faure G.C. Kinetics of specific salivary IgA responses in man after oral challenge by ribosomal immunostimulant. Int. J. Immunopharmacol. 1997, 19:181-186.
102. Lapiere J.C., Woodley D.T., Parente M.G., Iwasaki T., Wynn K.C., Christiano A.M., Uitto J. Epitope mapping of type VII collagen: Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J. Clin. Invest. 1993, 92:1831-1839.
103. Lehner T. Immunological aspects of recurrent oral ulceration and Behçet's syndrome. J. Oral Pathol. 1978, 7:424-430.
104. Lehner T. Regulation of immune responses to streptococcal protein antigens in dental caries. Immunol. Today 1982, 3:73-77.
105. Behçet's Syndrome 1979, Academic Press, London. T. Lehner, C.G. Barnes (Eds.).
106. Lehner T., Challacombe S.J., Wilton J., et al. Cellular and humoral immune responses in vaccination against dental caries in monkeys. Nature 1976, 264:69.
107. Lehner T., Lavery E., Smith R., van der Zee R., Mizushima Y., Shinnick T. Association between the 65-kilodalton heat shock protein, Stréptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect. Immun. 1991, 59:1434-1441.
108. Lehner T., Russell M.W., Caldwell J. Immunisation with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys. Lancet 1980, 1:995-996.
109. Lehner T., Russell M.W., Challacombe S.J., Scully E.M., Hawkes J. Passive immunisation with serum and immunoglobulin against dental caries in rhesus monkeys. Lancet 1978, 1:693-695.
110. Lehner T., Welsh K.I., Batchelor J.R. The relationship of HLA-B and DR phenotypes to Behçet's syndrome, recurrent oral ulceration and the class of immune complexes. Immunology 1982, 47:581-587.
111. Lehner T., Wilton J.M.A., Ivanyi L. Immunodeficiencies in chronic muco-cutaneous candidosis. Immunology 1972, 22:755-787.
112. Leventine A., Almeyda J. Drug reactions: 20 cutaneous reactions to anticonvulsants. Br. J. Dermatol. 1972, 87:246-249.
113. Li F., Michalek S.M., Dasanayake A.P., Li Y., Kirk K., Childers N.K. Intranasal immunization of humans with Streptococcus mutans antigens. Oral Microbiol. Immunol. 2003, 18:271-277.
114. Liebana J., Castillo A. Physiopathology of primary periodontitis associated with plaque. Microbial and host factors. A review, Part 1. Aust. Dent. J. 1994, 39:228-232.
115. Lifson A.R., Hilton J.F., Westenhouse Time from seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994, 8:73-79.
116. Loe H., Anerud A., Boysen H., Morrison E. Natural history of periodontal disease in man: Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J. Clin. Periodontol. 1986, 13:431-440.
117. Loiseau P., Lecleach L., Prost C., Lepage V., Busson M., Bastuji-Garin S., Roujeau J.C., Charron D. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J. Autoimmun. 2000, 15:67-73.
118. Lozada F., Silverman S. Erythema multiforme: Clinical characteristics and natural history in fifty patients. Oral Surg. Oral Med. Oral Pathol. 1978, 46:628-636.
119. Ma J.K.C., Hein M.B. Immunotherapeutic potential of antibodies produced in plants. TIBTECH 1995, 13:522-527.
120. Ma J.K.C., Lehner T. Prevention of colonization of Streptococcus mutans by topical application of monoclonal antibodies in human subjects. Arch. Oral Biol. 1990, 35:115S-122S.
121. Ma J.K., Vine N.D. Plant expression systems for the production of vaccines. Curr. Top. Microbiol. Immunol. 1999, 236:275-292.
122. Ma J.K.C., Hikmat B.Y., Wycoff K., Vine N.D., Chargelegue D., Yu L., Hein M.B., Lehner T. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 1998, 4:601-606.
123. Matthews J.B., Scully C.M., Potts A.J.C. Oral lichen planus: An immuno-peroxidase study using monoclonal antibodies to lymphocyte subsets. Br. J. Dermatol. 1984, III:587-595.
124. McArthur W.P., Clark W.B. Specific antibodies and their potential role in periodontal diseases. J. Periodontol. 1993, 64:807-818. (8 Suppl).
125. Mestecky J., Husby S., Moldoveanu Z., Waldo F.B., van den Wall Bake A.W., Elson C.O. Induction of tolerance in humans: Effectiveness of oral and nasal immunization routes. Ann. N.Y. Acad. Sci. 1996, 778:194-201.
126. Mestecky J., McGhee J.R., Arnold R.R., Michalek S.M., Prince S.J., Babb J.C. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J. Clin. Invest. 1978, 61:731-737.
127. Michalowicz B.S., Aeppli D., Virag J.G., Klump D.G., Hinrichs J.E., Segal N.L., Bouchard T.J., Pihlstrom B.L. Periodontal findings in adult twins. J. Periodontol. 1991, 62:293-299.
128. Miller M.F., Garfunkel A.A., Ram C.C., Ship I.I. Inheritance patterns in recurrent aphthous ulcers: Twin and pedigree data. Oral Surg. 1977, 43:836-891.
129. Miner J.H., Patton B.L., Lentz S.I., Gilbert D.J., Snider W.D., Jenkins N.A., Copeland N.G., Sanes J.R. The laminin a chains: Expression, developmental transitions, and chromosomal locations of a 1-5, identification of heterotrimeric laminis 8-11, and cloning of a novel a3 isoform. J. Cell Biol. 1997, 137:685-701.
130. Moutsopoulos H.M., Zerva L.V. Anti-Ro (SSA)/La (SSB) antibodies and Sjogren's syndrome. Clin. Rheumatol. 1990, 9:123-130.
131. Munro G.H.P., Evans S., Todryk P., Buckett C.G., Lehner T. A protein fragment of streptococcal cell surface antigen I/II which prevents adhesion of Streptococcus mutants. Infect. Immun. 1993, 61:4590-4598.
132. Nair P.N.R., Schroeder H.E. Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. Immunology 1986, 57:171-175.
133. O'Hagan D., Jeffery H., Maoloy K.H., Mowat A.M., Rahman D., Challacombe S.J. Biodegradable microparticles as oral vaccines. Adv. Exp. Med. Biol. 1995, 371B:1463-1467.
134. Olson R.G., Du Plessis D., Barron C., et al. Lichen planus dermopathy. Demonstration of lichen planus specific epidermal antigen in affected patients. J. Clin. Lab. Immun. 1983, 10:103-108.
135. Periodontitis in Man and Other Animals: A Comparative Review 1982, Karger, New York. R.C. Page, H.E. Schroeder (Eds.).
136. Palefsky J.M., Peñaranda M.E., Pierik L.T., Lagenaur L.A., MacPhail L.A., Greenspan D. Epstein-Barr virus BMRF-2 and BDLF-3 expression in hairy leukoplkia. Oral Dis. 1997, 3:S171-S176.
137. Palmer G.D., Robinson P.G., Challacombe S.J. Aetiological factors for the oral manifestations of HIV infection. Oral Dis. 1996, 2:193-197.
138. Pervin K., Childerstone A., Shinnick T., Mizushima Y., van der Zee R., Hasan A., Vaughan R., Lehner T. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J. Immunol. 1993, 151:2273-2282.
139. Phipps P.A., Stanford M.R., Sun J.B., Xiao B.G., Holmgren J., Schinnick T., Hasan A., Mizushima Y., Lehner T. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur. J. Immunol. 2003, 33:224-232.
140. Pilon M., Williams-Miller C., Cox D.S. Interleukin 2 in gingival crevicular fluid in periodontitis. J. Dent. Res. 1991, 70:550-555.
141. Price E., Venables P. The pathogenesis of Sjögren's syndrome. Semin. Arthritis Rheum. 1995, 25:117-133.
142. Quanter U., Kelmer I., Hoffmeister B., Sterry W. Induction and up regulation of adhesion receptors in oral and dermal lichen planus. J. Oral Pathol. Med. 1990, 19:459-463.
143. Rahman D., Challacombe S.J. Oral immunisation against mucosal candidiasis in a mouse model. Adv. Exp. Med. Biol. 1995, 371B:1663-1666.
144. Reynolds J. Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Dis. 1996, 2:70-76.
145. Rheinholdt J., Bay L., Svejgaard A. Association between HLA antigens and periodontal disease. J. Periodontal. 1977, 51:70-73.
146. Romani L., Mencacci A., Cenci E., Del Sero G., Bistonic F., Puccetti P. An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J. Immunol. 1997, 158:2356-2362.
147. Romani L., Mencacci A., Cenci E., Spaccapelo R., Toniatti C., Puccetti P., Bistoni F., Poli V. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 1996, 183:1345-1355.
148. Russell M.W., Challacombe S.J., Lehner T. Serum glucosyltransferase inhibiting antibodies and dental caries in rhesus monkeys immunized against Streptococcus mutans. Immunology 1976, 30:619-627.
149. Saito M., Otake S., Ohmura M., Hirasawa M., Takada K., Mega J., Takahashi I., Kiyono H., McGhee J.R., Takeda Y., Yamamoto M. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant. J. Infect. Dis. 2001, 183:823-826.
150. Salonen L., Axell T., Hellden L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J. Oral Pathol. Med. 1990, 19:170-176.
151. Sanderson J.D., Moss M.T., Tizard M.L.V., Herman T.J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992, 33:890-896.
152. Savage N.W., Barnard K., Shirlaw P.J., Rahman D., Mistry M., Escudier M.P., Sanderson J.D., Challacombe S.J. Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans, and Streptococcus mutans in orofacial granulomatosis and Crohn's disease. Clin. Exp. Immunol. 2004, 135:483-489.
153. Setterfield J., Shirlaw P.J., Bhogal B.S., Tilling K., Challacombe S.J., Black M.M. Cicatricial pemphigoid: Serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity. Br. J. Derm. 1999, 140:645-650.
154. Setterfield J., Shirlaw P.H., Kerr-Muir M., Bhogal B.S., Morgan P.R., Challacombe S.J., Tilling K., Black M.M. Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br. J. Dermatol. 1998, 138:602-610.
155. Seymour G.J., Gemmell E. Cytokines in periodontal disease: Where to from here?. Acta Odontol. Scand. 2001, 59:167-173.
156. Seymour G.J., Gemmell E., Kjeldsen M., Yamazaki K., Nakajima T., Hara K. Cellular immunity and hypersensitivity as components of periodontal destruction. Oral Dis. 1996, 2:96-101.
157. Shimizu H., Masunaga T., Ishiko A., et al. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane. J. Invest. Dermatol. 1995, 104:370-373.
158. Shirikata Y., Amagai M., Hanakawa Y., Nishikawa T., Hashimoto K. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J. Invest. Dermatol. 1998, 110:76-78.
159. Sinha A.A., Brautbar C., Szafer F., Friedmann A., Tzfoni E., Todd A.E., Steinman L., McDeuitt O.H. A newly characterised HLA-DQ allele associated with pemphigus vulagaris. Science 1988, 239:1026-1029.
160. Smith D.J. Dental caries vaccines: Prospects and concerns. Crit. Revs. Oral Biol. Med. 2002, 13:335-348.
161. Smith E.P., Taylor T.B., Meyer L.J., Zone J.J. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid. J. Invest. Dermatol. 1993, 101:619-623.
162. Soukka T., Tenovuo J., Rundegren J. Agglutination of Streptococcus mutans serotype C cells but inhibition of Porphyromonas gingivalis autoaggregation by human lactoferrin. Arch. Oral Biol. 1993, 38:227-232.
163. Stanford M.R., Kasp E., Whiston R., Hasan A., Todryk S., Shinnick T., Mizushima Y., Dumonde D.C., van der Zee R., Lehner T. Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin. Exper. Immunol. 1994, 97:226-231.
164. Studd M., McCance D.J., Lehner T. Detection of HSV-1 DNA in patients with Behçet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J. Med. Microbiol. 1991, 34:39-43.
165. Sun A., Hsieh R.P., Chu C.T., Ying C.W. Strong association of HLA-DRw9 in Chinese patients with recurrent oral ulcers. J. A. Acad. Dermatol. 1991, 24:195-198.
166. Sweet S.P., Challacombe S.J., Naglik J.R. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection. Adv. Exp. Med. Biol. 1995, 371B:1031-1034.
167. Sweet S.P., Rahman D., Challacombe S.J. IgA subclasses in HIV disease: Dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunology 1995, 86:556-559.
168. Syrjanen S., Karja V., Chang F.J., Johansson B., Syrjanen K. Epstein-Barr virus involvement in salivary gland lesions associated with Sjörgen's syndrome. ORL J. Otohinolaryngol. Relat. Spec. 1990, 52:254-259.
169. Talal N., Dauphinee M.J., Dang H., Alexander S.S., Hart D.J., Garry R.F. Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arthritis Rheum. 1990, 33:774-781.
170. Talal N., Sylvester R.A., Daniels T.E. T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome. J. Clin. Invest. 1974, 53:180-189.
171. Taubman M.A., Ebersole J.L., Smith D.J. Association between systemic and local antibody in periodontal disease. Host-Parasite Interactions in Periodontal Diseases 1982, 283-298. ASM Publications, Washington, DC. R.J. Genco, S.E. Mergenhagen (Eds.).
172. Tenovuo J., Moldoveanu Z., Mestecky J., Pruitt K.M., Rahhermtulla B.M. Interaction of specific and innate factors of immunity: IgA enhances the antimicrobial effect of the lactoperoxidase system against Streptococcus mutans. J. Immunol. 1982, 128:726-731.
173. Terasaki P.I., Kaslick R.S., West T.L., Chasens A.I. Low HLA frequency and periodontitis. Tissue Antigens 1975, 5:286-288.
174. Thomas D.W., Bagg J., Walker D.M. Characterization of the effector cells responsible for the in vitro cytotoxicity of blood leukocytes from aphthous ulcer patients for oral epithelial cells. Gut 1990, 31:294-299.
175. Thomas D.W., Stephens P., Stephens M., Patten D.W., Lim S.H. T-cell receptor V beta usage by lesional lymphocytes in oral lichen planus. J. Oral Pathol. Med. 1997, 26:105-109.
176. Tokoro Y., Matsuki Y., Yamamoto T., Suzuki T., Hara K. Relevance of local Th2-type cytokine mRNA expression in immuno-competent infiltrates in inflamed gingival tissue to periodontal diseases. Clin. Exp. Immunol. 1997, 107:166-174.
177. Traidl C., Sebastiani S., Albenisi C., et al. Disparate cytotoxic activity of nickel specific CD 8 positive and CD 4 positive T-cell subsets against keratinocytes. J. Immunol. 2000, 165:3058-3064.
178. Tsai C.C., McArthur W.P., Baehni P.C., Evian C.C., Genco J.R., Taichman S.N. Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J. Clin. Periodontol. 1981, 8:338-348.
179. Valdimarsson H., Higgs J.M., Wells R.S., Yamamura M., Hobbs J.R., Holt P.J. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell. Immunol. 1973, 6:348-361.
180. van Deventer S.J. Immunomodulation of Crohn's disease (review). Curr. Dir. Autoimmun. 2000, 2:150-166.
181. Venables P., Rigby S. Viruses in the etiopathogenesis of Sjögren's syndrome. J. Rheumatol. 1997, 24(Suppl. 50):3-5.
182. Wahl S.M., Wahl L.M. Modulation of fibroblast growth and function by monokines and lymphokines. Lymphokines 1981, 2:179-201.
183. Wakefield A.J., Sim R., Akbar A.N., Pounder R.E., Dhillon A.P. In situ immune responses in Crohn's disease: A comparison with acute and persistent measles virus infection. J. Med. Virol. 1997, 51:90-100.
184. Walton L.J., Macy M.G., Thornhill M.H., Farthing P.M. Intra epithelial subpopulations of T-lymphocytes and Langahan cells in oral lichen planus. J. Oral Pathol. Med. 1998, 27:116-123.
185. Walton L.J., Thornhill M.H., Farthing P.M. VCAM-1 and ICAM-1 are expressed by Langerhans cells, macrophages and endothelial cells in oral lichen plans. J. Oral Pathol. Med. 1994, 23:262-268.
186. Wiesenfeld D., Ferguson M.M., Mitchell D.N., MacDonald D.G., Scully C., Cochran K., Russll R.I. Orofacial granulomatosis-a clinical and pathological analysis. QJ. Med. 1985, 54:101-113.
187. Williams B.D., Lehner T. Immune complexes in Behçet's syndrome and recurrent oral ulceration. BMJ 1977, 1:1387-1389.
188. Wilson M., Henderson B. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol. Rev. 1995, 17:365-379.
189. Woodrow J.C. Immunogenetics of systemic lupus erythematosus. J. Rheumatol. 1988, 15:197-198.
190. Wray D. Oral manifestations of food allergy and intolerance. Food Allergy and Intolerance 2002, Saunders, London. 2nd ed. J. Brostoff, S.J. Challacombe (Eds.).
191. Yamamoto M., Fujihashi K., Hiroi T., McGhee J.R., Van Dyke T.E., Kiyono H. Molecular and cellular mechanisms for periodontal diseases: Rule of Th1 and Th2 type cytokines in induction of mucosal inflammation. J. Periodont. Res. 1997, 32:115-119.
192. Yancey K.B. Adhesion molecules. II: Interactions of keratinocytes with epidermal basement membrane. J. Invest. Dermatol. 1995, 104:1008-1014.
193. Zhou X.J., Savage N.W., Sugerman P.B., Walsh L.H., Aldred M.J., Seymour G.J. TCR V beta gene expression in lesional T lymphocyte cell lines in oral lichen planus. Oral Dis 1996, 2:295-298.